More Than 9,000 Taxotere Cases Over Long-Term Hair Loss Pending in MDL
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
«
»
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
A series of five bellwether trials for Taxotere hairloss lawsuits have been scheduled to begin in 2019.…
Four Taxotere hair loss claims have been selected as candidates for the first bellwether trial slated to begin in September.…
Lawsuits have been filed on behalf of more than 7,500 women who suffered permanent hair loss from Taxotere, claiming that the manufacturer failed to adequately warn about the risks associated with the breast cancer drug, which is not seen with other, equally effective treatment options.…
A federal judge has called for parties to select eight Taxotere hair loss lawsuits which could serve as the second Taxotere bellwether trial, scheduled for January 2019.…
The FDA has approved a cooling cap for widespread use in preventing hair loss from chemotherapy.…
More than 1,100 Taxotere lawsuits have been filed by women nationwide who say they suffered permanent hair loss due to the side effects of the chemotherapy drug.…
A motion has been filed to certify a Taxotere class action lawsuit over permanent hair loss problem experienced by women who received the controversial breast cancer drug.…
A Science Day for Taxotere litigation is scheduled for May 3, at which point the court will hear presentations on Taxotere chemotherapy and its links to permanent hair loss.…
More than 850 lawsuits have already been filed on behalf of women nationwide, who allege they have been left with permanent hair loss problems from Taxotere, a controversial breast cancer drug that plaintiffs indicate is no more effective than other treatment options, which do not carry the same risks.…